Table S2.
Assessment of reporting quality
General risk of bias items
|
Control items
|
Treatment items
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demographics reported | Baseline depression severity reported | Antidepressant use reported | Antidepressant use excluded | Adult MDD (>17 years and <60 years) | Concomitant medications reported | Similarly aged controls | Similar gender proportion in controls | Similar in other characteristics | Likelihood of high overall quality | Treated group demographics reported | All patients used same antidepressant | Change in depression noted | Likelihood of high overall quality | |
Bilici, 20001 | + | + | + | + | + | + | + | ? | + | + | + | − | + | + |
Galecki et al2 | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
Ghodake et al3 | ? | − | + | + | + | + | ? | ? | ? | ? | ? | − | − | − |
Khanzode et al4 | + | + | + | + | + | ? | + | ? | ? | + | + | − | + | + |
Kotan et al5 | + | + | + | + | + | + | + | + | + | + | + | − | + | + |
Baek and Park6 | + | + | − | − | + | − | + | + | + | + | ||||
Bajpai et al7 | ? | − | + | + | + | + | + | + | ? | + | ||||
Bal et al8 | + | − | + | + | + | + | + | + | + | + | ||||
Dimopoulos et al9 | + | + | + | + | ? | − | + | + | + | + | ||||
Fadillioglu et al10 | + | + | − | − | + | − | + | + | + | ? | ||||
Maes et al11 | + | + | + | − | + | ? | + | + | + | + | ||||
Maes et al12 | + | + | + | − | + | + | + | + | + | + | ||||
Rybka et al13 | + | + | + | − | + | − | + | + | + | + | ||||
Selley, 200314 | + | − | + | + | + | ? | + | + | + | + | ||||
Stefanescu and | + | + | + | − | + | ? | + | + | + | + | ||||
Ciobica15 | ||||||||||||||
Vargas et al16 | + | + | − | ? | + | − | + | + | + | + | ||||
Yager et al17 | + | − | + | + | + | + | + | + | + | + |
Note: The + represents that the study met that criterion, – represents that the study did not meet that criterion, ? represents that it was unclear whether the study met that criterion.
Abbreviation: MDD, major depressive disorder.